CVS Health Corporation (NYSE:CVS) Receives $91.67 Consensus PT from Analysts

Shares of CVS Health Corporation (NYSE:CVS) have earned an average recommendation of “Moderate Buy” from the twenty-six brokerages that are presently covering the company, Marketbeat Ratings reports. Four investment analysts have rated the stock with a hold recommendation, twenty have issued a buy recommendation and two have given a strong buy recommendation to the company. The average 12-month target price among brokerages that have issued ratings on the stock in the last year is $93.7143.

A number of brokerages have weighed in on CVS. Wells Fargo & Company lowered their price objective on CVS Health from $103.00 to $102.00 and set an “overweight” rating on the stock in a report on Thursday, November 13th. Wall Street Zen lowered CVS Health from a “buy” rating to a “hold” rating in a report on Saturday, November 1st. Jefferies Financial Group raised their price objective on CVS Health from $92.00 to $98.00 in a research note on Thursday, October 30th. UBS Group reiterated an “outperform” rating on shares of CVS Health in a research report on Wednesday. Finally, Raymond James Financial raised their price target on CVS Health from $75.00 to $90.00 in a research report on Friday, October 31st.

CVS Health Trading Down 1.7%

CVS opened at $79.45 on Wednesday. The company has a debt-to-equity ratio of 0.83, a quick ratio of 0.63 and a current ratio of 0.83. CVS Health has a one year low of $43.56 and a one year high of $85.15. The company has a market cap of $100.85 billion, a P/E ratio of 209.08, a PEG ratio of 0.78 and a beta of 0.48. The business’s 50-day simple moving average is $78.97 and its 200-day simple moving average is $71.98.

CVS Health (NYSE:CVS) last posted its earnings results on Wednesday, October 29th. The pharmacy operator reported $1.60 earnings per share for the quarter, topping the consensus estimate of $1.36 by $0.24. The firm had revenue of $102.87 billion during the quarter, compared to analysts’ expectations of $98.85 billion. CVS Health had a return on equity of 11.45% and a net margin of 0.12%.The firm’s revenue was up 7.8% compared to the same quarter last year. During the same quarter in the previous year, the business earned $1.09 earnings per share. CVS Health has set its FY 2025 guidance at 6.550-6.650 EPS. As a group, equities research analysts expect that CVS Health will post 5.89 EPS for the current fiscal year.

CVS Health Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Monday, November 3rd. Shareholders of record on Thursday, October 23rd were given a dividend of $0.665 per share. The ex-dividend date was Thursday, October 23rd. This represents a $2.66 dividend on an annualized basis and a yield of 3.3%. CVS Health’s payout ratio is presently 700.00%.

Institutional Inflows and Outflows

A number of hedge funds have recently modified their holdings of CVS. Benjamin Edwards Inc. lifted its position in shares of CVS Health by 14.6% in the first quarter. Benjamin Edwards Inc. now owns 32,810 shares of the pharmacy operator’s stock valued at $2,223,000 after acquiring an additional 4,182 shares in the last quarter. Nuveen LLC acquired a new position in CVS Health in the 1st quarter valued at about $204,421,000. Linscomb Wealth Inc. purchased a new position in CVS Health in the 1st quarter valued at about $215,000. AIA Group Ltd boosted its stake in shares of CVS Health by 4.1% during the 1st quarter. AIA Group Ltd now owns 29,287 shares of the pharmacy operator’s stock worth $1,984,000 after purchasing an additional 1,150 shares during the last quarter. Finally, Stone House Investment Management LLC acquired a new position in shares of CVS Health in the first quarter valued at approximately $39,000. 80.66% of the stock is owned by hedge funds and other institutional investors.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.